Subgroup-specific alternative splicing in medulloblastoma
Acta Neuropathologica , Volume 123 - Issue 4 p. 485- 499
Medulloblastoma comprises four distinct molecular variants: WNT, SHH, Group 3, and Group 4. We analyzed alternative splicing usage in 14 normal cerebellar samples and 103 medulloblastomas of known subgroup. Medulloblastoma samples have a statistically significant increase in alternative splicing as compared to normal fetal cerebella (2.3-times; P < 6.47E-8). Splicing patterns are distinct and specific between molecular subgroups. Unsupervised hierarchical clustering of alternative splicing events accurately assigns medulloblastomas to their correct subgroup. Subgroup-specific splicing and alternative promoter usage was most prevalent in Group 3 (19.4%) and SHH (16.2%) medulloblastomas, while observed less frequently in WNT (3.2%), and Group 4 (9.3%) tumors. Functional annotation of alternatively spliced genes reveals overrepresentation of genes important for neuronal development. Alternative splicing events in medulloblastoma may be regulated in part by the correlative expression of antisense transcripts, suggesting a possible mechanism affecting subgroup-specific alternative splicing. Our results identify additional candidate markers for medulloblastoma subgroup affiliation, further support the existence of distinct subgroups of the disease, and demonstrate an additional level of transcriptional heterogeneity between medulloblastoma subgroups.
|, , , ,|
|Organisation||Department of Neurology|
Dubuc, A.M, Morrissy, A.S, Kloosterhof, N.K, Northcott, P.A, Yu, E.P.Y, Shih, D.J.H, … Taylor, M.D. (2012). Subgroup-specific alternative splicing in medulloblastoma. Acta Neuropathologica, 123(4), 485–499. doi:10.1007/s00401-012-0959-7